HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,784 | -75.2% | 1,873 | -76.5% | 0.01% | -78.3% |
| Q2 2023 | $677,204 | +604546.4% | 7,954 | +487.0% | 0.02% | +475.0% |
| Q1 2023 | $112 | -15.2% | 1,355 | -19.3% | 0.00% | -20.0% |
| Q4 2022 | $132 | -100.0% | 1,679 | -64.8% | 0.01% | -16.7% |
| Q3 2022 | $354,000 | +63.1% | 4,774 | +43.4% | 0.01% | +20.0% |
| Q2 2022 | $217,000 | +250.0% | 3,330 | +238.8% | 0.01% | +400.0% |
| Q1 2022 | $62,000 | -85.1% | 983 | -87.4% | 0.00% | -85.7% |
| Q4 2021 | $415,000 | +68.7% | 7,807 | +124.4% | 0.01% | +16.7% |
| Q3 2021 | $246,000 | -22.4% | 3,479 | -26.9% | 0.01% | -25.0% |
| Q2 2021 | $317,000 | -77.5% | 4,761 | -62.5% | 0.01% | -66.7% |
| Q1 2021 | $1,408,000 | -13.1% | 12,681 | -7.1% | 0.02% | -52.0% |
| Q4 2020 | $1,621,000 | -33.2% | 13,645 | -50.9% | 0.05% | +85.2% |
| Q3 2020 | $2,425,000 | +59.3% | 27,791 | +63.5% | 0.03% | -56.5% |
| Q2 2020 | $1,522,000 | +1519.1% | 16,994 | +1709.8% | 0.06% | +933.3% |
| Q1 2020 | $94,000 | +754.5% | 939 | +839.0% | 0.01% | +500.0% |
| Q4 2019 | $11,000 | -88.7% | 100 | -87.0% | 0.00% | -85.7% |
| Q3 2019 | $97,000 | 0.0% | 768 | -4.6% | 0.01% | 0.0% |
| Q2 2019 | $97,000 | -68.3% | 805 | -77.0% | 0.01% | -63.2% |
| Q1 2019 | $306,000 | +3300.0% | 3,500 | +3969.8% | 0.02% | +1800.0% |
| Q4 2018 | $9,000 | -98.4% | 86 | -98.2% | 0.00% | -97.5% |
| Q3 2018 | $547,000 | +22.9% | 4,771 | -3.9% | 0.04% | +60.0% |
| Q2 2018 | $445,000 | -35.9% | 4,966 | -47.6% | 0.02% | -57.6% |
| Q1 2018 | $694,000 | +1679.5% | 9,480 | +1300.3% | 0.06% | +1080.0% |
| Q4 2017 | $39,000 | -86.7% | 677 | -89.7% | 0.01% | -79.2% |
| Q3 2017 | $294,000 | +583.7% | 6,552 | +495.6% | 0.02% | +380.0% |
| Q2 2017 | $43,000 | – | 1,100 | +54900.0% | 0.01% | – |
| Q1 2017 | $0 | -100.0% | 2 | -99.8% | 0.00% | -100.0% |
| Q4 2016 | $38,000 | -71.4% | 933 | -79.6% | 0.00% | -69.2% |
| Q2 2016 | $133,000 | +13200.0% | 4,574 | +12968.6% | 0.01% | – |
| Q4 2015 | $1,000 | -99.5% | 35 | -99.3% | 0.00% | -100.0% |
| Q2 2015 | $216,000 | -14.3% | 5,239 | -6.6% | 0.02% | -38.7% |
| Q1 2015 | $252,000 | +3050.0% | 5,610 | +2584.2% | 0.03% | +3000.0% |
| Q4 2014 | $8,000 | -96.7% | 209 | -97.0% | 0.00% | -96.3% |
| Q3 2014 | $245,000 | +371.2% | 7,025 | +380.5% | 0.03% | +285.7% |
| Q2 2014 | $52,000 | -37.3% | 1,462 | -42.8% | 0.01% | -36.4% |
| Q1 2014 | $83,000 | +336.8% | 2,554 | +457.6% | 0.01% | +266.7% |
| Q4 2013 | $19,000 | -91.5% | 458 | -91.9% | 0.00% | -87.5% |
| Q3 2013 | $224,000 | +220.0% | 5,632 | +231.3% | 0.02% | +300.0% |
| Q2 2013 | $70,000 | – | 1,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |